Prescription drug · ANDA
Benztropine Mesylate (Benztropine) NDC 69097-827
Benztropine mesylate 1 mg/1 · Tablet · Oral · Cipla USA Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 69097-827-02 | 6909708270269097082702 | 30 TABLET in 1 BOTTLE (69097-827-02)Marketed from Jun 29, 2016 | |
| 69097-827-07 | 6909708270769097082707 | 100 TABLET in 1 BOTTLE (69097-827-07)Marketed from Jun 29, 2016 | |
| 69097-827-15 | 6909708271569097082715 | 1000 TABLET in 1 BOTTLE (69097-827-15)Marketed from Jun 29, 2016 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Benztropine Mesylate
- Generic name (nonproprietary)
- benztropine
- Active ingredients
- Benztropine mesylate — 1 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Cipla USA Inc.NDC labeler code 69097
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 090294
- Marketing start
- Listing expires
- Other FDA classes
- Cholinergic Antagonists (Mechanism)Histamine Receptor Antagonists (Mechanism)
- Identifiers
- Product ID 69097-827_3d362141-de53-4949-b9a5-34f2b7bb0e75SPL ID 3d362141-de53-4949-b9a5-34f2b7bb0e75SPL set ID 3d2732f9-b8a9-4e83-91e7-da616ddcb786RxCUI 885209, 885213, 885219UNII WMJ8TL7510UPC 0369097826079, 0369097827076, 0369097832070
- Pharmacologic class
- Anticholinergic; Antihistamine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N469097082702followed by a unit qualifier and the quantityPackage 69097-0827-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE For use as an adjunct in the therapy of all forms of parkinsonism. Useful also in the control of extrapyramidal disorders (except tardive dyskinesia – see PRECAUTIONS ) due to neuroleptic drugs (e.g., phenothiazines).
Excerpt only. Read the full label for complete information.
About NDC 69097-827
- What is NDC 69097-827?
- 69097-827 is the product NDC for Benztropine Mesylate (benztropine), Benztropine mesylate 1 mg/1 tablet, listed with the FDA by Cipla USA Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Benztropine Mesylate (Benztropine).
- What is the active ingredient?
- Benztropine mesylate.
- Who is the labeler?
- Cipla USA Inc., NDC labeler code 69097. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Benztropine Mesylate?
- 55 other product NDCs are listed under this name. See all Benztropine Mesylate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Benztropine Mesylate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Benztropine Mesylate | Benztropine mesylate 1 mg/1 | TabletOral | Unit Dose Solutions, Inc. | 87441-012 | 87441-0012-01 |
| Benztropine Mesylate | Benztropine mesylate 2 mg/1 | TabletOral | Coupler LLC | 67046-0040 | 67046-0040-03 |
| Benztropine Mesylate | Benztropine mesylate 2 mg/1 | TabletOral | Coupler LLC | 67046-1675 | 67046-1675-03 |
| Benztropine Mesylate | Benztropine mesylate .5 mg/1 | TabletOral | Coupler LLC | 67046-1205 | 67046-1205-03 |
| Benztropine Mesylate | Benztropine mesylate .5 mg/1 | TabletOral | Coupler LLC | 67046-1674 | 67046-1674-03 |
| Benztropine Mesylate | Benztropine mesylate 1 mg/1 | TabletOral | Coupler LLC | 67046-0041 | 67046-0041-03 |
| Benztropine Mesylate | Benztropine mesylate .5 mg/1 | TabletOral | QUAGEN PHARMACEUTICALS LLC | 70752-123 | 70752-0123-1070752-0123-11 |
| Benztropine Mesylate | Benztropine mesylate 1 mg/1 | TabletOral | QUAGEN PHARMACEUTICALS LLC | 70752-124 | 70752-0124-1070752-0124-11 |
| Benztropine Mesylate | Benztropine mesylate 2 mg/1 | TabletOral | QUAGEN PHARMACEUTICALS LLC | 70752-125 | 70752-0125-1070752-0125-11 |
| Benztropine Mesylate | Benztropine mesylate .5 mg/1 | TabletOral | Bryant Ranch Prepack | 72162-2594 | 72162-2594-0072162-2594-0172162-2594-02 |
Other NDCs under ANDA 090294
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Benztropine Mesylatebenztropine | Benztropine mesylate .5 mg/1 | TabletOral | Cipla USA Inc. | 69097-826 |
| Benztropine Mesylatebenztropine | Benztropine mesylate 2 mg/1 | TabletOral | Cipla USA Inc. | 69097-832 |